Novamexx India Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 6.71 M
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.98 Cr
- Revenue Growth 24.66%
- Profit Growth 221.70%
- Ebitda 141.89%
- Net Worth 3.55%
- Total Assets 13.65%
About Novamexx India
Novamexx India Private Limited (NIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 November 2008 and has a history of 16 years and two months. Its registered office is in Delhi, India.
The Corporate was formerly known as Joyfill India Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 6.71 M.
The company currently has active open charges totaling ₹8.98 Cr.
Anil Gupta and Ajay Panday serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120DL2008PTC184721
-
Company No.
184721
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Nov 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Novamexx India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Gupta
|
Director | 10-Nov-2008 | Current |
|
Ajay Panday
|
Director | 02-Jun-2020 | Current |
Financial Performance of Novamexx India.
Novamexx India Private Limited, for the financial year ended 2015, experienced significant growth in revenue, with a 24.66% increase. The company also saw a substantial improvement in profitability, with a 221.7% increase in profit. The company's net worth moved up by a moderate rise of 3.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novamexx India?
In 2015, Novamexx India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.98 Cr
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 8.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2010 | Corporation Bank | ₹2.00 Cr | Open |
| 02 May 2009 | Corporation Bank | ₹6.98 Cr | Open |
How Many Employees Work at Novamexx India?
Novamexx India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novamexx India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novamexx India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
